Open house discount agreements for Ibuprofen, ATC M01AE01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 219 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Structured notice only

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ibuprofen, ATC M01AE01

50/100

Score d'opportunité

Needs reviewMedium complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

50 / 100

Complexité

35 / 100

Facteurs de risque

The open house agreements automatically expire when a competitive discount agreement for the same active substance come...

Strict submission rules for paper and electronic submissions; missing documents may be requested but could delay contra...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until May 2027
Non-exclusive discount agreements for Ibuprofen (ATC M01AE01)
Open house model with no competition – all eligible pharmaceutical companies can join

Afficher le résumé complet

Open house model for non-exclusive discount agreements on Ibuprofen (ATC M01AE01) with AOK Bayern. All eligible pharmaceutical companies can join. No competitive selection. Contract term 24 months from 1 June 2025. Submission possible at any time until 5 April 2027.

Risques

The open house agreements automatically expire when a competitive discount agreement for the same active substance come...

Strict submission rules for paper and electronic submissions; missing documents may be requested but could delay contra...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

Only pharmaceutical companies are eligible

Administrative

Must submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
Must submit the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Les exigences peuvent être incomplètes.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house discount agreements for Ibuprofen, ATC M01AE01

Non-exclusive discount agreements for Ibuprofen (ATC M01AE01) with all interested pharmaceutical companies. Open house model, not a competitive procedure. Contract duration 1 June 2025 to 31 May 2027.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Apr 05, 2027

Détails de la procédure

Date de publication: 15 Apr 2025
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 249200-2025

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3